
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Splice-Modulating Antisense Oligonucleotides as Therapeutics for Inherited Metabolic Diseases
Suxiang Chen, Saumya Nishanga Heendeniya, Bao T. Le, et al.
BioDrugs (2024) Vol. 38, Iss. 2, pp. 177-203
Open Access | Times Cited: 21
Suxiang Chen, Saumya Nishanga Heendeniya, Bao T. Le, et al.
BioDrugs (2024) Vol. 38, Iss. 2, pp. 177-203
Open Access | Times Cited: 21
Showing 21 citing articles:
Synthesis and Application of 4′-C-[(N-alkyl)aminoethyl]thymidine Analogs for Optimizing Oligonucleotide Properties
Kanji Fujiki, Yuri Kakisawa, Elsayed M. Mahmoud, et al.
Molecules (2025) Vol. 30, Iss. 3, pp. 581-581
Open Access
Kanji Fujiki, Yuri Kakisawa, Elsayed M. Mahmoud, et al.
Molecules (2025) Vol. 30, Iss. 3, pp. 581-581
Open Access
Pathogenetic therapeutic approaches for endocrine diseases based on antisense oligonucleotides and RNA-interference
Olga O. Golounina, Илдар Минниахметов, Р. Р. Салахов, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Olga O. Golounina, Илдар Минниахметов, Р. Р. Салахов, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
The Progress and Evolving Trends in Nucleic-Acid-Based Therapies
Yunlong Liu, Changjun Wang, Xiuping Fu, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 376-376
Open Access
Yunlong Liu, Changjun Wang, Xiuping Fu, et al.
Biomolecules (2025) Vol. 15, Iss. 3, pp. 376-376
Open Access
RNA-based therapeutics—Mechanisms and challenges
Gazala Afreen Khan, Aliasgar Shahiwala
Elsevier eBooks (2025), pp. 189-225
Closed Access
Gazala Afreen Khan, Aliasgar Shahiwala
Elsevier eBooks (2025), pp. 189-225
Closed Access
In Utero Gene Therapy and its Application in Genetic Hearing Loss
Chenyang Kong, Ge Yin, Xiaohui Wang, et al.
Advanced Biology (2024) Vol. 8, Iss. 10
Closed Access | Times Cited: 3
Chenyang Kong, Ge Yin, Xiaohui Wang, et al.
Advanced Biology (2024) Vol. 8, Iss. 10
Closed Access | Times Cited: 3
Inhibition of survivin by 2′-O-methyl phosphorothioate-modified steric-blocking antisense oligonucleotides
Yalin Li, Suxiang Chen, Kamal Rahimizadeh, et al.
RSC Advances (2024) Vol. 14, Iss. 19, pp. 13336-13341
Open Access | Times Cited: 2
Yalin Li, Suxiang Chen, Kamal Rahimizadeh, et al.
RSC Advances (2024) Vol. 14, Iss. 19, pp. 13336-13341
Open Access | Times Cited: 2
New insights into polysaccharide-based nanostructured delivery systems in breast cancer: Possible application of antisense oligonucleotides in breast cancer therapy
Fahimeh Shayegh, Zeynep Türk, Arta Armani, et al.
International Journal of Biological Macromolecules (2024) Vol. 272, pp. 132890-132890
Closed Access | Times Cited: 2
Fahimeh Shayegh, Zeynep Türk, Arta Armani, et al.
International Journal of Biological Macromolecules (2024) Vol. 272, pp. 132890-132890
Closed Access | Times Cited: 2
Mitochondrial trifunctional protein deficiency caused by a deep intronic deletion leading to aberrant splicing
Thomas Cassini, Sarah Silverstein, Molly Behan, et al.
JIMD Reports (2024) Vol. 66, Iss. 1
Open Access | Times Cited: 2
Thomas Cassini, Sarah Silverstein, Molly Behan, et al.
JIMD Reports (2024) Vol. 66, Iss. 1
Open Access | Times Cited: 2
Therapeutic Antisense Oligonucleotides in Oncology: From Bench to Bedside
Elif Çakan, Olivia D. Lara, Anna Szymanowska, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 2940-2940
Open Access | Times Cited: 2
Elif Çakan, Olivia D. Lara, Anna Szymanowska, et al.
Cancers (2024) Vol. 16, Iss. 17, pp. 2940-2940
Open Access | Times Cited: 2
RNA structure in alternative splicing regulation: from mechanism to therapy
Nengcheng Bao, Zhechao Wang, Jiayan Fu, et al.
Acta Biochimica et Biophysica Sinica (2024)
Open Access | Times Cited: 1
Nengcheng Bao, Zhechao Wang, Jiayan Fu, et al.
Acta Biochimica et Biophysica Sinica (2024)
Open Access | Times Cited: 1
Rational Design of Chimeric Antisense Oligonucleotides on a Mixed PO–PS Backbone for Splice-Switching Applications
Bao T. Le, Suxiang Chen, Rakesh N. Veedu
Biomolecules (2024) Vol. 14, Iss. 7, pp. 883-883
Open Access | Times Cited: 1
Bao T. Le, Suxiang Chen, Rakesh N. Veedu
Biomolecules (2024) Vol. 14, Iss. 7, pp. 883-883
Open Access | Times Cited: 1
Antisense oligonucleotides in rare neurogenetic disorders
Hui Jin Shin, Ara Ko, Jiyoung Oh, et al.
Journal of Genetic Medicine (2024) Vol. 21, Iss. 2, pp. 41-50
Open Access | Times Cited: 1
Hui Jin Shin, Ara Ko, Jiyoung Oh, et al.
Journal of Genetic Medicine (2024) Vol. 21, Iss. 2, pp. 41-50
Open Access | Times Cited: 1
RNA splicing as a therapeutic target in myelodysplastic syndromes
C.-C. Tseng, Esther A. Obeng
Seminars in Hematology (2024)
Open Access | Times Cited: 1
C.-C. Tseng, Esther A. Obeng
Seminars in Hematology (2024)
Open Access | Times Cited: 1
A deep intronic variant in MME causes autosomal recessive Charcot-Marie-Tooth neuropathy through aberrant splicing
Bianca R. Grosz, Jevin Parmar, Melina Ellis, et al.
(2024)
Closed Access
Bianca R. Grosz, Jevin Parmar, Melina Ellis, et al.
(2024)
Closed Access
Exploiting functional regions in the viral RNA genome as druggable entities
Dehua Luo, Yingge Zheng, Zhiyuan Huang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Dehua Luo, Yingge Zheng, Zhiyuan Huang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Prospects for gene therapy in polycystic kidney disease
Anubhav Chakraborty, Alan S.L. Yu
Current Opinion in Nephrology & Hypertension (2024)
Closed Access
Anubhav Chakraborty, Alan S.L. Yu
Current Opinion in Nephrology & Hypertension (2024)
Closed Access
Evaluating the breadth of nucleic acid-based payloads delivered in lipid nanoparticles to establish fundamental differences in development
Jinjin Li, Camilla Foged
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 10, pp. 1441-1461
Closed Access
Jinjin Li, Camilla Foged
Expert Opinion on Drug Delivery (2024) Vol. 21, Iss. 10, pp. 1441-1461
Closed Access
Evolution of antisense oligonucleotides: navigating nucleic acid chemistry and delivery challenges
Ruchi Ruchi, Govind Mukesh Raman, Vikas Kumar, et al.
Expert Opinion on Drug Discovery (2024)
Closed Access
Ruchi Ruchi, Govind Mukesh Raman, Vikas Kumar, et al.
Expert Opinion on Drug Discovery (2024)
Closed Access
Gene therapy for hearing loss: challenges and the promise of cellular plasticity and epigenetic modulation
Samprita Das, Uri Manor
Frontiers in Neurology (2024) Vol. 15
Open Access
Samprita Das, Uri Manor
Frontiers in Neurology (2024) Vol. 15
Open Access
Exploiting functional regions in the viral RNA genome as druggable entities
Dehua Luo, Yingge Zheng, Zhiyuan Huang, et al.
(2024)
Open Access
Dehua Luo, Yingge Zheng, Zhiyuan Huang, et al.
(2024)
Open Access
Exploiting functional regions in the viral RNA genome as druggable entities
Dehua Luo, Yingge Zheng, Zhiyuan Huang, et al.
(2024)
Open Access
Dehua Luo, Yingge Zheng, Zhiyuan Huang, et al.
(2024)
Open Access